Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 May 2019 | Story Lacea Loader | Photo Robin Thuynsma
Mr Nikile Ntsababa
Mr Nikile Ntsababa.

Mr Nikile Ntsababa took up the position of Registrar at the University of the Free State (UFS) on 1 May 2019. His appointment was approved by the UFS Council during its quarterly meeting on 15 March 2019.
 
“Mr Ntsababa is an experienced and knowledgeable university registrar with 10 years of senior management experience in institutional compliance, regulatory compliance, academic administration, and university records management. His history of senior roles in the higher-education sector has the advantage of a very good understanding regarding the dynamics, context, and challenges that the position of registrar brings,” says Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.
 
He holds a Postgraduate Diploma in Records and Archives Management from the University of Fort Hare, a Master of Public Administration from Nelson Mandela University, and a Bachelor of Arts in Communication from the University of Fort Hare. Some of the further certification and short courses he has completed includes a Certificate in International Higher Education Management from Vanderbilt University, Tennessee State in the USA, and a Compliance Management Certificate from the University of Cape Town. He is a Certified Ethics Officer.
 
Mr Ntsababa was Registrar at the Cape Peninsula University of Technology (CPUT) from April 2012 to April 2019; before that he was Deputy Registrar at CPUT from April 2009 to March 2012. He also served as Director of Governance at the University of Fort Hare from September 2007 to March 2009, and as Faculty Manager: Management and Commerce at the University of Fort Hare from January 2004 to August 2007.   
 
“I look forward to working at the UFS and to share my knowledge and experience of higher-education legislation and the associated regulatory processes, requirements, and trends in the higher-education sector,” says Mr Ntsababa.

Released by:

Lacea Loader (Director: Communication and Marketing)

Telephone: +27 51 401 2584 | +27 83 645 2454

Email: news@ufs.ac.za | loaderl@ufs.ac.za

Fax: +27 51 444 6393



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept